FDA recall D-1055-2020

Lupin Pharmaceuticals Inc. · Class III · drug

Product

Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estradiol tablets USP, 0.01 mg), packaged in 1 Wallet of 28 Tablets (NDC 68180-879-11), 3 Wallets of 28 Tablets Each per carton (NDC 68180-879-13), Rx Only, Distributed by: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Pithampur (M.P.) - 454775, INDIA.

Reason for recall

Failed Content Uniformity Specifications: Out Of Specification test results observed for content and blend uniformity.

Distribution

Nationwide in the USA and Puerto Rico.

Key facts

Status
Terminated
Initiation date
2020-03-09
Report date
2020-03-18
Termination date
2021-05-25
Voluntary/Mandated
Voluntary: Firm initiated
Location
Baltimore, MD, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1055-2020